Evotec SE (EVO) Non-Current Debt (2020 - 2026)
Evotec SE's (EVO) quarterly Non-Current Debt came in at $349873.8 in Q1 2026, down 20.39% year-on-year from $439465.7 in Q1 2025, and down 12.63% quarter-over-quarter from $400440.3 in Q4 2025.
Evotec SE (EVO) Non-Current Debt (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Non-Current Debt across 7 years of filings, most recently posting $349873.8 for Q1 2026.
- Non-Current Debt for Q1 2026 came in at $349873.8, down 20.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $349873.8 (down 20.39% YoY), and the FY2025 annual result was $400440.3, down 99.9% from the prior year.
- Non-Current Debt came in at $349873.8 for Q1 2026 at Evotec SE, down from $400440.3 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $513.3 million in Q4 2023 to a low of -$349703.3 in Q2 2022.
- The 5-year median for Non-Current Debt is $420776.3 (2025), against an average of $119.7 million.
- Across the five-year window, Non-Current Debt surged 33.99% in 2022 and slumped 99.9% in 2025, its largest moves.
- Evotec SE's Non-Current Debt stood at $500.2 million in 2022, then advanced by 2.62% to $513.3 million in 2023, then dropped by 18.25% to $419.7 million in 2024, then plunged by 99.9% to $400440.3 in 2025, then slipped by 12.63% to $349873.8 in 2026.
- The last three Non-Current Debt figures came in at $349873.8 (Q1 2026), $400440.3 (Q4 2025), and $453294.1 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 569.60 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | 349,873.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 349,873.83 |
| Mar 31, 2026 | 349,873.83 |
| Dec 31, 2025 | 400,440.28 |
| Dec 31, 2025 | 400,440.28 |
| Sep 30, 2025 | 453,294.10 |
| Sep 30, 2025 | 453,294.10 |
| Jun 30, 2025 | 402,086.80 |
| Jun 30, 2025 | 402,086.80 |
| Mar 31, 2025 | 439,465.75 |
| Mar 31, 2025 | 439,465.75 |
| Dec 31, 2024 | 419.68 Mn |
| Dec 31, 2024 | 419.68 Mn |
| Sep 30, 2024 | 457,423.80 |
| Sep 30, 2024 | 457,423.80 |
| Dec 31, 2023 | 513.34 Mn |
| Dec 31, 2023 | 513.34 Mn |
| Dec 31, 2022 | 500.22 Mn |
| Dec 31, 2022 | 500.22 Mn |
| Sep 30, 2022 | 329,479.85 |
| Sep 30, 2022 | 329,479.85 |